Cannabidiol for cannabis use disorder: too high hopes? - Authors' reply.

Saved in:
Bibliographic Details
Title: Cannabidiol for cannabis use disorder: too high hopes? - Authors' reply.
Authors: Freeman TP; Addiction and Mental Health Group, Department of Psychology, University of Bath, Bath BA2 7AY, UK; Clinical Psychopharmacology Unit, University College London, London, UK; Translational Psychiatry Research Group, Research Department of Mental Health Neuroscience, Division of Psychiatry, University College London, London, UK; National Addiction Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK. Electronic address: t.p.freeman@bath.ac.uk., Hindocha C; Clinical Psychopharmacology Unit, University College London, London, UK; Translational Psychiatry Research Group, Research Department of Mental Health Neuroscience, Division of Psychiatry, University College London, London, UK; National Institute for Health Research, University College London Hospitals Biomedical Research Centre, London, UK., Baio G; Department of Statistical Science, University College London, London, UK., Curran HV; Clinical Psychopharmacology Unit, University College London, London, UK; National Institute for Health Research, University College London Hospitals Biomedical Research Centre, London, UK.
Source: The lancet. Psychiatry [Lancet Psychiatry] 2020 Oct; Vol. 7 (10), pp. 840.
Publication Type: Letter; Comment
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 101638123 Publication Model: Print Cited Medium: Internet ISSN: 2215-0374 (Electronic) Linking ISSN: 22150366 NLM ISO Abbreviation: Lancet Psychiatry Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2215-0374
DOI:10.1016/S2215-0366(20)30376-X